Role of soluble interleukin-2 receptor (sIL-2R) as a predictor for severe dengue infection

被引:0
|
作者
Singh, Arkit Deep [1 ]
Saroch, Atul [1 ]
Pannu, Ashok Kumar [1 ]
Yadav, Ashok Kumar [2 ]
Sharda, Saurabh C. [1 ]
Bhatia, Mandeep [1 ]
Kamboj, Kajal [2 ]
机构
[1] PGIMER Chandigarh, Nehru Hosp, Dept Internal Med, Room 11,4th Floor F Block, Chandigarh, India
[2] PGIMER Chandigarh, Dept Expt Med & Biotechnol, Chandigarh, India
来源
SCIENTIFIC REPORTS | 2025年 / 15卷 / 01期
关键词
ACTIVATION; DIAGNOSIS; RECEPTOR; CHILDREN; DISEASE; SCORE; SERA;
D O I
10.1038/s41598-025-91274-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Annually, around half a million people with severe dengue require hospitalization, all over the globe, with around 12,500 (2.5%) succumbing to the illness. In this prospective observational study, we recruited 74 patients with dengue infection, 28 had severe dengue and 46 had dengue with warning signs. sIL-2R levels were significantly raised in the severe dengue group, compared to the warning signs group. Using an ROC curve (receive operator characteristic), at a cutoff of 5.379 ng/ml, it predicted the severe dengue classification with a p-value of < 0.001. As a marker for predicting hemophagocytic lymphohistiocytosis (HLH), the ROC curve revealed a cutoff of >= 5.379 ng/ml for sIL-2R levels with the AUROC being 0.83, suggesting a strong diagnostic performance(p-value < 0.001). sIL-2R levels can be used for predicting severe dengue classification with moderate sensitivity and specificity. Secondary HLH is an under-reported entity in dengue infection and early surveillance with the help of sIL-2R may be helpful in-patient care management.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] INCREASED LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR (SIL-2R) INVIVO IN SKIN-LESIONS OF LEPROSY REVERSAL REACTIONS
    SCOLLARD, DM
    WAGNER, D
    SURIYANOND, V
    SMITH, T
    RANGDAENG, S
    THEETRANONT, C
    JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 42 (04) : 397 - 397
  • [32] EFFECTS OF ALPHA-INTERFERON AND PREDNISONE ON SERUM-SOLUBLE INTERLEUKIN-2 RECEPTOR (SIL-2R) IN CHRONIC HEPATITIS-B INFECTION
    LEUNG, NWY
    LEUNG, JCK
    TAM, JS
    LAU, JTF
    LAI, KN
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1992, 87 (01): : 113 - 117
  • [33] Plasma vWF levels correlate with soluble interleukin-2 receptor (sIL-2R) levels in type 2 diabetics with retinopathy.
    Karayalcin, U
    Timuragaoglu, A
    Balci, MK
    Karadogan, I
    Altunbas, H
    Undar, L
    DIABETOLOGIA, 1997, 40 : 1549 - 1549
  • [34] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON SOLUBLE INTERLEUKIN-2 RECEPTOR (SIL-2R) LEVELS IN HEMODIALYSIS-PATIENTS
    ALTUN, B
    ERDEM, Y
    HAZNEDAROGLU, I
    GURSOY, M
    YASAVUL, U
    TURGAN, C
    CAGLAR, S
    KIRAZLI, S
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (11) : 2164 - 2164
  • [35] SOLUBLE INTERLEUKIN-2 RECEPTOR (SIL-2R) LEVELS IN RENAL-TRANSPLANTATION - COMPARISON BETWEEN CLINICAL AND LABORATORY ANALYSIS
    MONTAGNINO, G
    TARANTINO, A
    GRIGNANI, S
    BRAGA, M
    PONTICELLI, C
    CLINICAL TRANSPLANTATION, 1995, 9 (01) : 25 - 30
  • [36] Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder
    ODonnell, MC
    Catts, SV
    Ward, PB
    Liebert, B
    Lloyd, A
    Wakefield, D
    McConaghy, N
    PSYCHIATRY RESEARCH, 1996, 65 (03) : 171 - 178
  • [37] Serum concentrations of soluble interleukin-2 receptors (sIL-2R) in patients with benign and malignant ovarian tumors
    Gebauer, G
    Rieger, M
    Jaeger, W
    Lang, N
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 547 - 547
  • [38] SOLUBLE INTERLEUKIN-2 RECEPTOR (SIL-2R) MONITORING PROVIDES AN INDICATION OF IMMUNE STATUS IN ADULT LIVER-TRANSPLANT RECIPIENTS
    ROSSI, SJ
    SCHROEDER, TJ
    HANTO, D
    HEPATOLOGY, 1992, 16 (04) : A289 - A289
  • [39] Plasma vWF levels correlate with plasma soluble interleukin-2 receptor (sIL-2R) levels in type 2 diabetics with background retinopathy
    Timuragaoglu, A
    Balci, MK
    Karadogan, I
    Altunbas, H
    Ozturk, F
    Karayalcin, U
    Undar, L
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS458 - PS458
  • [40] CHANGES IN SOLUBLE INTERLEUKIN-2 RECEPTOR (SIL-2R) LEVELS IN CANCER-PATIENTS RECEIVING RECOMBINANT INTERLEUKIN-2(RIL-2) AND LYMPHOKINE ACTIVATED KILLERS (LAK)
    MARSHALL, GD
    RUCKER, KT
    PRICE, JO
    COPENHAVER, JD
    WEST, WH
    JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 42 (04) : 362 - 362